| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |